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A R T I C L E  I N F O A B S T R A C T
The between method variability of patient results is 
a source of uncertainty that can have adverse con-
sequences for patient safety and clinical outcomes. 
Globalisation requires that laboratory medicine results 
should be transferable between methods. Traceability 
in laboratory medicine aims to reduce between meth-
od variability so that results are independent of time 
or location. Application of the metrological traceability 
chain facilitates a universal approach based around the 
preparation, adoption and use of higher order interna-
tional commutable reference materials and reference 
measurement procedures, supported by expert ref-
erence laboratories. Global collaboration is required, 
involving several different stakeholder groups ranging 
from international experts to laboratory medicine spe-
cialists in routine clinical laboratories.
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INTRODUCTION
Laboratory medicine results influence a high per-
centage of all clinical decisions. Patients expect 
that different laboratories, using different meth-
ods, will give the same result for an analyte mea-
sured in a clinical sample. Often this is not the 
case and an inappropriate clinical decision for 
a patient may be the consequence. Laboratory 
medicine specialists have a professional respon-
sibility to provide a high-quality service that is 
optimised to the needs of the patient [1].
Traceability in laboratory medicine aims to re-
duce between method variability so that results 
are independent of time or location [2]. Achieving 
traceability is a global multi-stakeholder coop-
erative activity involving metrologists; interna-
tional standards organisations; scientific and 
clinical experts from international professional 
bodies; healthcare regulators; and the in-vitro 
diagnostics (IVD) industry that is responsible for 
the manufacture and sale of diagnostic testing 
systems [3]. The Joint Committee for Traceability 
in Laboratory Medicine (JCTLM) was established 
to co-ordinate the activity of these stakeholders, 
to provide educational support for traceability, 
and to establish and maintain a database of ref-
erence materials, reference methods and refer-
ence laboratories [4].
THE IMPORTANCE  
OF REDUCING BETWEEN-METHOD  
AND BETWEEN-LABORATORY VARIABILITY
There are several reasons why efforts should 
be made to reduce between-method and be-
tween-laboratory variability [5]. These include:
• Improving patient safety 
• Facilitating patient empowerment 
• Ensuring public confidence 
• Enabling consolidation and networking
• Supporting laboratory accreditation 
• Implementing evidence-based clinical 
guidelines 
• Guaranteeing clinical governance 
• Adopting common informatics 
• Introducing the electronic patient record
TRACEABILITY IN LABORATORY 
MEDICINE AND THE METROLOGICAL 
TRACEABILITY CHAIN
Metrology is the science of measurement. The 
basics of measurement involve:
• A measurable property, known as a quantity 
(e.g. concentration)
• Definition of the measurand – the quantity 
that is intended to be measured. The de-
scription of the measurand should include 
the matrix (e.g. plasma); the component 
(analyte) of interest, and the amount of 
substance concentration
• The units in which the measurement will be 
made. Metrological traceability requires the 
international system of units (SI) or units 
with well-established conversions
• The uncertainty with which the measure-
ment can be made
Metrological traceability is the property of a 
measurement result, which can be related to 
a reference through a documented unbroken 
chain of calibrations. The principles of a ref-
erence measurement system for establishing 
metrological traceability are described in the 
ISO17511:2003 document [6]. The components 
of a reference measurement system comprise 
reference materials (calibrators) and measure-
ment procedures (methods), both of which ex-
ist at different hierarchical levels.
The inter-relationship between the components 
of a reference measurement system describes 
the metrological traceability chain [6]. Figure 1 
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reference materials and measurement proce-
dures at the top and lower order towards the 
bottom. This hierarchy is depicted by the ris-
ing ‘metrological traceability’ arrow. Descent 
through the traceability chain is accompanied 
by increasing measurement uncertainty as de-
picted by the downward arrow.
The traceability status of an individual measure-
ment result depends on the existence of an un-
broken chain to higher order materials and/or 
measurement procedures. To be effective the 
unbroken chain requires commutable materials 
[7] and sufficiently low imprecision at each step. 
In the case of structurally simple molecules, 
like many of those measured routinely in clini-
cal chemistry, it is possible to have a complete 
unbroken chain to primary reference measure-
ment procedures and primary reference materi-
als. Even for some protein molecules it is possible 
to achieve full metrological traceability by using 
a unique, signature peptide as the primary refer-
ence material. The measurement of serum cho-
lesterol and blood haemoglobin A1c are examples 
of full metrological traceability where the agree-
ment between methods is excellent [3]. Serum 
parathyroid hormone and blood haemoglobin A2 
are examples where the between-method vari-
ability is unacceptably high, causing clinical risk. 
In both these cases method standardisation/har-
monisation initiatives have commenced [3].
For many biological materials, including com-
plex proteins and viruses it is not possible to 
prepare secondary calibrators. In these circum-
stances international conventional calibrators 
are adopted as being the highest order materi-
als available. The global acceptance of such in-
ternational conventional calibrators can facili-
tate reduced between method variability.



























































Adapted from EN ISO 17511 2003 [6]
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SOURCES OF REFERENCE MATERIALS  
AND REFERENCE MEASUREMENT 
PROCEDURES 
The JCTLM maintains a database of refer-
ence materials, reference measurement pro-
cedures and reference laboratories [8]. Strict 
criteria are required for inclusion in the JCTLM 
database, including evidence of commutabil-
ity of reference materials and measurement 
uncertainty.
The World Health Organization Expert Committee 
for Biological Standardization (WHO-ECBS) main-
tains a catalogue of international conventional 
calibrators for blood products and biological 
stan dards [9].
CHALLENGES IN IMPLEMENTING 
TRACEABILITY IN LABORATORY MEDICINE 
AT A GLOBAL LEVEL
There are several challenges to implementing 
global traceability [3]. These include:
• Geographical differences
• Lack of uniformity of units
• Complex analytes
• Global coordination
STAKEHOLDERS IN IMPLEMENTING 
TRACEABILITY IN LABORATORY MEDICINE
The stakeholders involved in delivering trace-
ability in laboratory medicine into routine prac-
tice are summarised in Figure 2.
Figure 2 Global stakeholders involved in delivering traceability 
in laboratory medicine into routine practice
Define clinical decision values 
and analytical requirements
Provide reference materials 
and reference methods
List available materials and 
methods. Promote traceability
Raise analytical and clinical 
quality targets
Produce higher-order methods 
with commutable calibrators
Use commutable materials to 
monitor method performance








Standards / accreditation /
professional bodies
Global database of reference
materials & methods
National metrology institutes
Professional bodies / societies
Internationally recognised expert
clinical / laboratory committees
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The initiative begins at the bottom of the trian-
gle with international recognition of the need 
for traceability for a specific analyte. Thereafter, 
international and national standards organisa-
tions and metrology institutes are responsible 
for producing and listing the available reference 
materials and measurement procedures. These 
are used by the IVD method manufacturers to 
produce the methods made available for routine 
use with their performance evaluated through 
external quality assessment (EQA) schemes 
based on commutable control materials.
ACTION PLAN TO IMPLEMENT 
TRACEABILITY IN LABORATORY MEDICINE  
AT A GLOBAL LEVEL
The implementation of traceability in laboratory 
medicine at a global level requires a coordinated 
action plan. This can be derived from Figure 2 
by assigning actions to each of the seven stake-
holder groups [3].
1. Internationally recognised expert clinical/
laboratory committees:
• Develop international consortium for 
communication and sharing informa-
tion on the need for traceability
• Prioritise and agree methods that re-
quire harmonisation and issue invita-
tions to expert groups to undertake 
method harmonisation projects [10]
2. National metrology institutes/international 
professional bodies/societies:
• Develop commutable reference materi-
als and measurement procedures for 
individual analytes to the highest avail-
able order of metrological traceability
• Publish the outcome of harmonisation 
projects in peer-reviewed scientific 
literature
3. Global database of reference materials and 
methods:
• Using freely available lists and cata-
logues publicise available reference 
materials and methods that meet 
agreed standards, including information 
on commutability and measurement 
uncertainty
• Provide educational support materials 
to promote the importance of trace-
ability in laboratory medicine
4. Standards/accreditation/professional bodies:
• Include traceability in laboratory medi-
cine in the training of laboratory medi-
cine specialists and in the standards 
required for laboratory accreditation
• Provide educational support materials 
to promote the importance of trace-
ability in laboratory medicine
5. IVD method manufacturers:
• Produce IVD methods that conform 
with the highest available order of met-
rological traceability
• Provide details of the traceability status 
of methods in the information for use 
documentation
6. EQA providers:
• Promote the use of commutable EQA 
materials
• Provide educational support about 
traceability for EQA scheme participants
7. Routine laboratory medicine specialists:
• Know the traceability status of the 
methods used and understand the 
measurement uncertainty involved
• Educate staff about traceability in labo-
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Resources for educational support are available 
from JCTLM [4]. Readers of this article are invited 
to discuss with their peers how they can contrib-
ute to the coordinated action plan.
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